ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer

ClinicalTrials.gov ID: NCT00981656

Public ClinicalTrials.gov record NCT00981656. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 5:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging

Study identification

NCT ID
NCT00981656
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Radiation Therapy Oncology Group
Network
Enrollment
37 participants

Conditions and interventions

Conditions

Interventions

  • 5-fluorouracil Drug
  • Mitomycin Drug
  • Three-Dimensional Conformal Radiation Therapy Radiation
  • cisplatin Drug

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2009
Primary completion
Feb 28, 2021
Completion
Aug 14, 2023
Last update posted
Sep 18, 2024

2009 – 2023

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Emory Crawford Long Hospital Atlanta Georgia 30308
Winship Cancer Institute of Emory University Atlanta Georgia 30322
St. Agnes Hospital Cancer Center Baltimore Maryland 21229
Hudner Oncology Center at Saint Anne's Hospital - Fall River Fall River Massachusetts 02721
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0002
Beth Israel Medical Center - Petrie Division New York New York 10003-3803
Summa Center for Cancer Care at Akron City Hospital Akron Ohio 44309-2090
Barberton Citizens Hospital Barberton Ohio 44203
Cancer Care Center, Incorporated Salem Ohio 44460
Cancer Treatment Center Wooster Ohio 44691
Fox Chase Cancer Center - Philadelphia Philadelphia Pennsylvania 19111-2497
University of Texas Medical Branch Galveston Texas 77555-0361
Norris Cotton Cancer Center - North Saint Johnsbury Vermont 05819

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00981656, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00981656 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →